Nausea and Vomiting During Pregnancy

Brandon Williamson, MD
Katie Jo Light, MD
Hector Chapa, MD

American Family Physician. 2026;113(6):559-565.

Author disclosure: No relevant financial relationships.

This clinical content conforms to AAFP criteria for CME.

Nausea and vomiting are some of the most common symptoms during pregnancy. Severity should be assessed with a tool such as the Pregnancy-Unique Quantification of Emesis and Nausea (PUQE) score. In severe cases, additional medical history should be obtained to rule out possible secondary causes. Treatment depends on the severity of symptoms, beginning with behavioral modification such as trigger avoidance and dietary changes for mild cases. Modification includes meals that are small, frequent, bland, dry, and high in protein. First-line pharmacologic management for mild or moderate cases is vitamin B6 with or without doxylamine. When conservative measures are ineffective or not tolerated, additional pharmacologic options include other antihistamines or dopamine antagonists. Metoclopramide and ondansetron are considered second-line treatments for persistent symptoms. Dehydration and electrolyte abnormalities should be corrected and may necessitate hospitalization if oral intake is not possible. Treatment of refractory or severe symptoms include the consideration of corticosteroids and, in rare cases, supplemental enteral or parenteral nutrition.

BRANDON WILLIAMSON, MD, FAAFP, is a clinical associate professor and associate department head in the Department of Primary Care and Rural Medicine at the Texas A&M University Naresh K. Vashisht College of Medicine, Bryan.

KATIE JO LIGHT, MD, MSCP, is a clinical associate professor in the Texas A&M Family Medicine Residency and Department of Primary Care and Rural Medicine at the Texas A&M University Naresh K. Vashisht College of Medicine, Bryan.

HECTOR CHAPA, MD, FACOG, is a clinical associate professor in the Department of Primary Care and Rural Medicine at the Texas A&M University Naresh K. Vashisht College of Medicine, College Station.

Address correspondence to Brandon Williamson, MD, at bwilliamson@tamu.edu.

Author disclosure: No relevant financial relationships.

  1. 1.Fejzo MS, et al. Nausea and vomiting of pregnancy and hyperemesis gravidarum. Nat Rev Dis Primers. 2019;5(1):62.
  2. 2.Lowe SA, et al. The SOMANZ position statement on the management of nausea and vomiting in pregnancy and hyperemesis gravidarum. Updated October 2023. Accessed March 26, 2025. https://somanz.org/content/uploads/2023/12/SOMANZ-Management-of-NVP-Position-Statement-Updated-Oct-2023-FINAL-1.pdf
  3. 3.Gadsby R, et al. Nausea and vomiting in pregnancy is not just ‘morning sickness’: data from a prospective cohort study in the UK. Br J Gen Pract. 2020;70(697):e534-e539.
  4. 4.Lacroix R, et al. Nausea and vomiting during pregnancy: a prospective study of its frequency, intensity, and patterns of change. Am J Obstet Gynecol. 2000;182(4):931-937.
  5. 5.Jansen LAW, et al. The windsor definition for hyperemesis gravidarum: a multistakeholder international consensus definition. Eur J Obstet Gynecol Reprod Biol. 2021;266:15-22.
  6. 6.Committee on Practice Bulletins–Obstetrics. ACOG practice bulletin no. 189: nausea and vomiting of pregnancy. Obstet Gynecol. 2018;131(1):e15-e30.
  7. 7.Fiaschi L, et al. Hospital admission for hyperemesis gravidarum: a nationwide study of occurrence, reoccurrence and risk factors among 8.2 million pregnancies. Hum Reprod. 2016;31(8):1675-1684.
  8. 8.Fejzo MS, et al.; 23andMe Research Team. Placenta and appetite genes GDF15 and IGFBP7 are associated with hyperemesis gravidarum. Nat Commun. 2018;9(1):1178.
  9. 9.Fejzo MS, et al. Analysis of GDF15 and IGFBP7 in hyperemesis gravidarum support causality. Geburtshilfe Frauenheilkd. 2019;79(4):382-388.
  10. 10.Fejzo MS, et al. GDF15 linked to maternal risk of nausea and vomiting during pregnancy. Nature. 2024;625(7996):760-767.
  11. 11.Czeizel AE, et al. The effect of periconceptional multivitamin-mineral supplementation on vertigo, nausea and vomiting in the first trimester of pregnancy. Arch Gynecol Obstet. 1992;251(4):181-185.
  12. 12.Emelianova S, et al. Prevalence and severity of nausea and vomiting of pregnancy and effect of vitamin supplementation. Clin Invest Med. 1999;22(3):106-110.
  13. 13.Fejzo MS, et al. Pregnant, miserable, and starving in 21st century America. AJOG Glob Rep. 2022;3(1):100141.
  14. 14.Geeganage G, et al. Emergency department burden of hyperemesis gravidarum in the United States from 2006 to 2014. AJOG Glob Rep. 2023;3(1):100166.
  15. 15.Gazal A, et al. What are the costs associated with nausea and vomiting in pregnancy and hyperemesis gravidarum? A systematic review. BMC Pregnancy Childbirth. 2025;25(1):807.
  16. 16.Trovik J, et al. Hyperemesis gravidarum is associated with substantial economic burden in addition to severe physical and psychological suffering. Isr J Health Policy Res. 2016;5:43.
  17. 17.Gete KY, et al. The impact of nausea and vomiting on health related quality of life during pregnancy: a systematic review. BMC Pregnancy Childbirth. 2025;26(1):20.
  18. 18.Mitchell-Jones N, et al. Psychological morbidity associated with hyperemesis gravidarum: a systematic review and meta-analysis. BJOG. 2017;124(1):20-30.
  19. 19.Senturk MB, et al. The relationship between hyperemesis gravidarum and maternal psychiatric well-being during and after pregnancy: controlled study. J Matern Fetal Neonatal Med. 2017;30(11):1314-1319.
  20. 20.Nana M, et al. Hyperemesis gravidarum is associated with increased rates of termination of pregnancy and suicidal ideation: results from a survey completed by >5000 participants. Am J Obstet Gynecol. 2021;224(6):629-631.
  21. 21.Lassey SC, et al. Rhabdomyolysis after hyperemesis gravidarum. Obstet Gynecol. 2016;128(1):195-196.
  22. 22.Giugale LE, et al. Iatrogenic Wernicke encephalopathy in a patient with severe hyperemesis gravidarum. Obstet Gynecol. 2015;125(5):1150-1152.
  23. 23.Lerner JC, et al. Hyperemesis gravidarum presenting to the emergency department with Wernicke encephalopathy: a case report. J Emerg Crit Care Med. 2024;8:15.
  24. 24.Dayangan Sayan C. A case of prolonged hyperemesis resulting in hepatorenal failure, foetal distress and neonatal mortality. J Obstet Gynaecol. 2018;38(4):573-575.
  25. 25.Nguyen N, et al. Splenic avulsion in a pregnant patient with vomiting. Can J Surg. 1995;38(5):464-465.
  26. 26.Scarborough A, et al. Spontaneous pneumomediastinum secondary to hyperemesis gravidarum: a case report and principles of recognition and management. Case Rep Womens Health. 2020;28:e00257.
  27. 27.Eroğlu A, et al. Spontaneous esophageal rupture following severe vomiting in pregnancy. Dis Esophagus. 2002;15(3):242-243.
  28. 28.Fejzo MS, et al. Why are women still dying from nausea and vomiting of pregnancy?. Gynecol Obstet Case Rep. 2016;2(2).
  29. 29.Koren G, et al. The protective effects of nausea and vomiting of pregnancy against adverse fetal outcome—a systematic review. Reprod Toxicol. 2014;47:77-80.
  30. 30.Bolin M, et al. Hyperemesis gravidarum and risks of placental dysfunction disorders: a population-based cohort study. BJOG. 2013;120(5):541-547.
  31. 31.Fejzo MS, et al. Analysis of neurodevelopmental delay in children exposed in utero to hyperemesis gravidarum reveals increased reporting of autism spectrum disorder. Reprod Toxicol. 2019;84:59-64.
  32. 32.Whitehouse AJO, et al. Symptom severity in autism spectrum disorder is related to the frequency and severity of nausea and vomiting during pregnancy: a retrospective case-control study. Mol Autism. 2018;9:37.
  33. 33.Getahun D, et al. Autism spectrum disorders in children exposed in utero to hyperemesis gravidarum. Am J Perinatol. 2021;38(3):265-272.
  34. 34.Fogh MV, et al. School performance in offspring born to mothers with hyperemesis gravidarum. Am J Obstet Gynecol. 2025;233(3):205. e1-205.e12.
  35. 35.Khachadourian V, et al. Familial confounding in the associations between maternal health and autism. Nat Med. 2025;31(3):996-1007.
  36. 36.Lacasse A, et al. Validity of a modified Pregnancy-Unique Quantification of Emesis and Nausea (PUQE) scoring index to assess severity of nausea and vomiting of pregnancy. Am J Obstet Gynecol. 2008;198(1):71.e1-71.e7.
  37. 37.Bischoff SC, et al. Nausea and nutrition. Auton Neurosci. 2006;129(1):22-27.
  38. 38.Power ML, et al. A survey on the management of nausea and vomiting in pregnancy by obstetrician/gynecologists. Prim Care Update Ob Gyns. 2001;8(2):69-72.
  39. 39.Jednak MA, et al. Protein meals reduce nausea and gastric slow wave dysrhythmic activity in first trimester pregnancy. Am J Physiol. 1999;277(4):G855-G861.
  40. 40.McParlin C, et al. Treatments for hyperemesis gravidarum and nausea and vomiting in pregnancy: a systematic review. JAMA. 2016;316(13):1392-1401.
  41. 41.Matthews A, et al. Interventions for nausea and vomiting in early pregnancy. Cochrane Database Syst Rev. 2015(9):CD007575.
  42. 42.Viljoen E, et al. A systematic review and meta-analysis of the effect and safety of ginger in the treatment of pregnancy-associated nausea and vomiting. Nutr J. 2014;13(1):20.
  43. 43.Nelson-Piercy C, et al.; Royal College of Obstetricians and Gynaecologists. The management of nausea and vomiting in pregnancy and hyperemesis gravidarum (Green-top guideline no. 69). BJOG. 2024;131(7):e1-e30.
  44. 44.Lu H, et al. Effectiveness of acupuncture in the treatment of hyperemesis gravidarum: a systematic review and meta-analysis. Evid Based Complement Alternat Med. 2021:2731446.
  45. 45.Furyk JS, et al. Drugs for the treatment of nausea and vomiting in adults in the emergency department setting. Cochrane Database Syst Rev. 2015(9):CD010106.
  46. 46.Mayhall EA, et al. Comparison of antiemetics for nausea and vomiting of pregnancy in an emergency department setting. Am J Emerg Med. 2015;33(7):882-886.
  47. 47.Madjunkova S, et al. The delayed-release combination of doxylamine and pyridoxine (Diclegis®/Diclectin®) for the treatment of nausea and vomiting of pregnancy. Paediatr Drugs. 2014;16(3):199-211.
  48. 48.Maltepe C, et al. Preemptive treatment of nausea and vomiting of pregnancy: results of a randomized controlled trial. Obstet Gynecol Int. 2013;2013(1):809787.
  49. 49.Boelig RC, et al. Interventions for treating hyperemesis gravidarum. Cochrane Database Syst Rev. 2016(5):CD010607.
  50. 50.Jayawardena R, et al. The effects of pyridoxine (vitamin B6) supplementation in nausea and vomiting during pregnancy: a systematic review and meta-analysis. Arch Gynecol Obstet. 2023;308(4):1075-1084.
  51. 51.Magee LA, et al. Evidence-based view of safety and effectiveness of pharmacologic therapy for nausea and vomiting of pregnancy (NVP). Am J Obstet Gynecol. 2002;186(5):S256-S261.
  52. 52.Tan PC, et al. Promethazine compared with metoclopramide for hyperemesis gravidarum: a randomized controlled trial. Obstet Gynecol. 2010;115(5):975-981.
  53. 53.Svendsen K, et al. Reported time to onset of neurological adverse drug reactions among different age and gender groups using metoclopramide: an analysis of the global database Vigibase®. Eur J Clin Pharmacol. 2018;74(5):627-636.
  54. 54.Sun L, et al. Use of metoclopramide in the first trimester and risk of major congenital malformations: a systematic review and meta-analysis. PLoS One. 2021;16(9):e0257584.
  55. 55.US Food and Drug Administration. Drug label information— reglan tablets. Updated February 9, 2026. Accessed May 10, 2026. https://www.accessdata.fda.gov/drugsatfda_docs/label/2026/017854s071lbl.pdf
  56. 56.Mitchell AA, et al.; National Birth Defects Prevention Study. Medication use during pregnancy, with particular focus on prescription drugs: 1976–2008. Am J Obstet Gynecol. 2011;205(1):51.e1-51.e8.
  57. 57.Parker SE, et al.; National Birth Defects Prevention Study. Ondansetron for treatment of nausea and vomiting of pregnancy and the risk of specific birth defects. Obstet Gynecol. 2018;132(2):385-394.
  58. 58.Kashifard M, et al. Ondansetrone or metoclopromide? Which is more effective in severe nausea and vomiting of pregnancy? A randomized trial double-blind study. Clin Exp Obstet Gynecol. 2013;40(1):127-130.
  59. 59.Abas MN, et al. Ondansetron compared with metoclopramide for hyperemesis gravidarum: a randomized controlled trial. Obstet Gynecol. 2014;123(6):1272-1279.
  60. 60.Picot C, et al. Risk of malformation after ondansetron in pregnancy: an updated systematic review and meta-analysis. Birth Defects Res. 2020;112(13):996-1013.
  61. 61.Cao X, et al. Risk of abnormal pregnancy outcomes after using ondansetron during pregnancy: a systematic review and meta-analysis. Front Pharmacol. 2022;13:951072.
  62. 62.Gill SK, et al. The effect of acid-reducing pharmacotherapy on the severity of nausea and vomiting of pregnancy. Obstet Gynecol Int. 2009;2009(1):585269.
  63. 63.Kothari S, et al. AGA clinical practice update on pregnancy-related gastrointestinal and liver disease: expert review. Gastroenterology. 2024;167(5):1033-1045.
  64. 64.Klauser CK, et al. Treatment of severe nausea and vomiting of pregnancy with subcutaneous medications. Am J Perinatol. 2011;28(9):715-721.
  65. 65.Reichmann JP, et al. Reviewing the evidence for using continuous subcutaneous metoclopramide and ondansetron to treat nausea & vomiting during pregnancy. Manag Care. 2012;21(5):44-47.
  66. 66.Guttuso T Jr, et al. Effect of gabapentin on hyperemesis gravidarum: a double-blind, randomized controlled trial. Am J Obstet Gynecol MFM. 2021;3(1):100273.
  67. 67.McCarthy FP, et al. Day care compared with inpatient management of nausea and vomiting of pregnancy: a randomized controlled trial. Obstet Gynecol. 2014;124(4):743-748.
  68. 68.Mitchell-Jones N, et al. Ambulatory versus inpatient management of severe nausea and vomiting of pregnancy: a randomised control trial with patient preference arm. BMJ Open. 2017;7(12):e017566.
  69. 69.Ryan N, et al. The case for day case: reduced inpatient stays with the use of day case management in hyperemesis study. Curr Womens Health Rev. 2019;15(2):130-136.
  70. 70.Clark SM, et al. Inpatient management of hyperemesis gravidarum. Obstet Gynecol. 2024;143(6):745-758.
  71. 71.Westfall RE, et al. Survey of medicinal cannabis use among childbearing women: patterns of its use in pregnancy and retroactive self-assessment of its efficacy against ‘morning sickness’. Complement Ther Clin Pract. 2006;12(1):27-33.
  72. 72.First OK, et al. Patterns of use and self-reported effectiveness of cannabis for hyperemesis gravidarum. Geburtshilfe Frauenheilkd. 2022;82(5):517-527.
  73. 73.Herrell HE. Nausea and vomiting of pregnancy. Am Fam Physician. 2014;89(12):965-970.
  74. 74.Quinlan JD, et al. Nausea and vomiting of pregnancy. Am Fam Physician. 2003;68(1):121-128.

Copyright © 2026 by the American Academy of Family Physicians.

This content is owned by the AAFP. A person viewing it online may make one printout of the material and may use that printout only for his or her personal, non-commercial reference. This material may not otherwise be downloaded, copied, printed, stored, transmitted or reproduced in any medium, whether now known or later invented, except as authorized in writing by the AAFP. See permissions for copyright questions and/or permission requests.